4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-044546
CEO sold 3,020 shares at $2.25 ($6,795)
From the SEC's structured data for this filing
Trades in this filing
Shah Gaurav · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-13 | Sale : show line 1 in the form | −3,020 | $2.25 | $6,795 | 1,053,574 | D |
| Open-market sales · 3,020 sh · avg $2.25 · $6,795 | ||||||
Loading xslF345X06/form4.xml…